CASI Pharmaceuticals (NASDAQ:CASI) Earns Hold Rating from Analysts at StockNews.com

StockNews.com initiated coverage on shares of CASI Pharmaceuticals (NASDAQ:CASI – Free Report) in a research note released on Friday morning. The firm issued a hold rating on the biotechnology company’s stock. CASI Pharmaceuticals Stock Performance Shares of CASI Pharmaceuticals stock opened at $3.11 on Friday. CASI Pharmaceuticals has a one year low of $1.85 and […]

Related Keywords

United States , ,Pharmaceuticals Inc ,Virtu Financial ,Pharmaceuticals Daily ,Pharmaceuticals Stock Performance ,Susquehanna International Group ,Citigroup Inc ,Renaissance Technologies ,Pharmaceuticals Company Profile ,Free Report ,International Group ,Get Free Report ,Casi Pharmaceuticals ,Nasdaq Casi ,Casi ,Medical ,Initiated Coverage ,Stocknews Com ,